$USNU
Elite Health Systems Inc.

2024 Q1 Form 10-Q Financial Statement

#000114036124026235 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $476.0K $130.0K
YoY Change 266.15% -63.89%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $476.0K $130.0K
YoY Change 266.15% -63.89%
Operating Profit -$476.0K -$130.0K
YoY Change 266.15% -63.89%
Interest Expense $1.000K $3.000K
YoY Change -66.67%
% of Operating Profit
Other Income/Expense, Net $1.000K $3.000K
YoY Change -66.67% -102.26%
Pretax Income -$475.0K -$127.0K
YoY Change 274.02% -74.24%
Income Tax -$163.0K $0.00
% Of Pretax Income
Net Earnings -$312.0K -$108.0K
YoY Change 188.89% -74.35%
Net Earnings / Revenue
Basic Earnings Per Share -$0.03 -$0.01
Diluted Earnings Per Share -$0.03 -$0.01
COMMON SHARES
Basic Shares Outstanding 13.30M 7.842M
Diluted Shares Outstanding 11.90M 7.842M

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.750M $1.281M
YoY Change 36.61% -22.74%
Cash & Equivalents $1.750M $1.281M
Short-Term Investments
Other Short-Term Assets $56.00K $19.00K
YoY Change 194.74% -59.57%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.806M $1.300M
YoY Change 38.92% -23.75%
LONG-TERM ASSETS
Property, Plant & Equipment $80.00K $10.00K
YoY Change 700.0% -79.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $191.0K $137.0K
YoY Change 39.42% -6.16%
Other Assets $714.0K $277.0K
YoY Change 157.76% -71.3%
Total Long-Term Assets $794.0K $287.0K
YoY Change 176.66% -80.54%
TOTAL ASSETS
Total Short-Term Assets $1.806M $1.300M
Total Long-Term Assets $794.0K $287.0K
Total Assets $2.600M $1.587M
YoY Change 63.83% -50.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $75.00K $65.00K
YoY Change 15.38% -63.28%
Accrued Expenses $27.00K $12.00K
YoY Change 125.0% -72.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.202M $247.0K
YoY Change 791.5% -60.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $65.00K $11.00K
YoY Change 490.91% -52.17%
Total Long-Term Liabilities $65.00K $11.00K
YoY Change 490.91% -52.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.202M $247.0K
Total Long-Term Liabilities $65.00K $11.00K
Total Liabilities $2.267M $258.0K
YoY Change 778.68% -74.83%
SHAREHOLDERS EQUITY
Retained Earnings -$2.702M -$1.818M
YoY Change 48.62%
Common Stock $3.035M $2.949M
YoY Change 2.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $333.0K $1.131M
YoY Change
Total Liabilities & Shareholders Equity $2.600M $1.587M
YoY Change 63.83% -50.09%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$312.0K -$108.0K
YoY Change 188.89% -74.35%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$461.0K -$130.0K
YoY Change 254.62% -61.31%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$126.0K
YoY Change -100.0% -31.52%
Cash From Investing Activities $0.00 -$126.0K
YoY Change -100.0% -31.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.745M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -461.0K -130.0K
Cash From Investing Activities 0.000 -126.0K
Cash From Financing Activities 1.745M 0.000
Net Change In Cash 1.284M -256.0K
YoY Change -601.56% -50.77%
FREE CASH FLOW
Cash From Operating Activities -$461.0K -$130.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1806000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
333000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
645000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
466000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
714000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2600000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1321000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
466000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
527000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
189000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-126000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1745000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1284000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1750000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
56000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
61000
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
191000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
709000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
80000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
85000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85000
CY2024Q1 us-gaap Assets
Assets
2600000
CY2023Q4 us-gaap Assets
Assets
1321000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
27000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
27000
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
75000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
59000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
93000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
93000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2942000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2942000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2390000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
476000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
130000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
476000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
130000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-476000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-130000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-475000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-127000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-163000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-312000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-127000
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-19000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-312000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-108000
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11899210
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11899210
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7842185
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7842185
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1456000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
645000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-312000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-256000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1537000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1750000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1281000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
523000
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
520000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
166000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2202000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
607000
CY2024Q1 usnu Amount Of Guarantee Obligations Noncurrent
AmountOfGuaranteeObligationsNoncurrent
11000
CY2023Q4 usnu Amount Of Guarantee Obligations Noncurrent
AmountOfGuaranteeObligationsNoncurrent
11000
CY2024Q1 us-gaap Liabilities
Liabilities
2267000
CY2023Q4 us-gaap Liabilities
Liabilities
676000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5000
CY2023 us-gaap Profit Loss
ProfitLoss
-816000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
333000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-312000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-127000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
10000
CY2024Q1 usnu Income Loss From Equity Method Investments Net
IncomeLossFromEquityMethodInvestmentsNet
-2000
CY2023Q1 usnu Income Loss From Equity Method Investments Net
IncomeLossFromEquityMethodInvestmentsNet
-3000
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
23000
CY2024Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-166000
CY2023Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-1000
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-5000
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-20000
CY2024Q1 usnu Increase Decrease In Operating Lease Right Of Use Liability
IncreaseDecreaseInOperatingLeaseRightOfUseLiability
4000
CY2023Q1 usnu Increase Decrease In Operating Lease Right Of Use Liability
IncreaseDecreaseInOperatingLeaseRightOfUseLiability
11000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-461000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-130000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2702000
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001089815
CY2024Q1 us-gaap Financing Receivable After Allowance For Credit Loss Noncurrent Related Party Type Extensible Enumeration
FinancingReceivableAfterAllowanceForCreditLossNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4 us-gaap Financing Receivable After Allowance For Credit Loss Noncurrent Related Party Type Extensible Enumeration
FinancingReceivableAfterAllowanceForCreditLossNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
0-15586
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
U.S. NeuroSurgical Holdings, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5370333
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1131 W 6th Street
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Ontario
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91672
CY2024Q1 dei City Area Code
CityAreaCode
949
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
249-1170
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13484924
CY2024Q1 usnu Private Placement Advances Pending For Allotment
PrivatePlacementAdvancesPendingForAllotment
2100000
CY2023Q4 usnu Private Placement Advances Pending For Allotment
PrivatePlacementAdvancesPendingForAllotment
355000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
58000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9284924
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9284924
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9284924
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9284924
CY2024Q1 us-gaap Interest Expense
InterestExpense
1000
CY2023Q1 us-gaap Interest Expense
InterestExpense
0
CY2024Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
2000
CY2023Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
3000
CY2023 usnu Stock Issued During Period Value Pending Certification
StockIssuedDuringPeriodValuePendingCertification
81000
CY2023 usnu Movement From Noncontrolling Interest To Retained Earnings
MovementFromNoncontrollingInterestToRetainedEarnings
-81000
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0
CY2024Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
3000
CY2023Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
0
CY2024Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
0
CY2023Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
126000
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1745000
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-816000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1572000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-312000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-108000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2702000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1750000
CY2024Q1 usnu Working Capital Deficit
WorkingCapitalDeficit
-396000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
80000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10000
CY2024Q1 usnu Total Leased Assets Operating And Financing
TotalLeasedAssetsOperatingAndFinancing
80000
CY2023Q1 usnu Total Leased Assets Operating And Financing
TotalLeasedAssetsOperatingAndFinancing
10000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
27000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12000
CY2024Q1 usnu Total Lease Liabilities Operating And Finance
TotalLeaseLiabilitiesOperatingAndFinance
81000
CY2023Q1 usnu Total Lease Liabilities Operating And Finance
TotalLeaseLiabilitiesOperatingAndFinance
24000
CY2024Q1 us-gaap Lease Cost
LeaseCost
5000
CY2023Q1 us-gaap Lease Cost
LeaseCost
10000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
20000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
30000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
31000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
81000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
0
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
81000
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0414
CY2023 usnu Income Loss From Advances To Affiliate
IncomeLossFromAdvancesToAffiliate
0
CY2024Q1 usnu Income Loss From Advances To Affiliate
IncomeLossFromAdvancesToAffiliate
0
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9284924
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9284924
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0

Files In Submission

Name View Source Status
0001140361-24-026235-index-headers.html Edgar Link pending
0001140361-24-026235-index.html Edgar Link pending
0001140361-24-026235.txt Edgar Link pending
0001140361-24-026235-xbrl.zip Edgar Link pending
ef20026325_10q.htm Edgar Link pending
ef20026325_ex31-1.htm Edgar Link pending
ef20026325_ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usnu-20240331.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
usnu-20240331_cal.xml Edgar Link unprocessable
usnu-20240331_def.xml Edgar Link unprocessable
usnu-20240331_lab.xml Edgar Link unprocessable
usnu-20240331_pre.xml Edgar Link unprocessable
ef20026325_10q_htm.xml Edgar Link completed